nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—SLCO4C1—Methotrexate—systemic scleroderma	0.327	0.524	CbGbCtD
Saxagliptin—ABCC1—Methotrexate—systemic scleroderma	0.0886	0.142	CbGbCtD
Saxagliptin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0819	0.131	CbGbCtD
Saxagliptin—SLC22A8—Methotrexate—systemic scleroderma	0.0689	0.11	CbGbCtD
Saxagliptin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.032	0.0512	CbGbCtD
Saxagliptin—CYP3A4—Prednisone—systemic scleroderma	0.0255	0.0409	CbGbCtD
Saxagliptin—DPP8—smooth muscle tissue—systemic scleroderma	0.00581	0.128	CbGeAlD
Saxagliptin—DPP4—blood vessel—systemic scleroderma	0.0052	0.115	CbGeAlD
Saxagliptin—DPP9—tendon—systemic scleroderma	0.00479	0.106	CbGeAlD
Saxagliptin—DPP8—tendon—systemic scleroderma	0.00436	0.0965	CbGeAlD
Saxagliptin—DPP9—lung—systemic scleroderma	0.00421	0.0931	CbGeAlD
Saxagliptin—DPP8—lung—systemic scleroderma	0.00383	0.0847	CbGeAlD
Saxagliptin—DPP4—connective tissue—systemic scleroderma	0.00267	0.059	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—systemic scleroderma	0.00244	0.054	CbGeAlD
Saxagliptin—SLCO4C1—lung—systemic scleroderma	0.00242	0.0536	CbGeAlD
Saxagliptin—DPP4—digestive system—systemic scleroderma	0.00193	0.0426	CbGeAlD
Saxagliptin—DPP4—tendon—systemic scleroderma	0.00183	0.0405	CbGeAlD
Saxagliptin—DPP4—lung—systemic scleroderma	0.00161	0.0356	CbGeAlD
Saxagliptin—Angioedema—Mometasone—systemic scleroderma	0.00112	0.00339	CcSEcCtD
Saxagliptin—Erectile dysfunction—Mycophenolic acid—systemic scleroderma	0.00112	0.00338	CcSEcCtD
Saxagliptin—Urinary tract infection—Leflunomide—systemic scleroderma	0.0011	0.00334	CcSEcCtD
Saxagliptin—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.00108	0.00328	CcSEcCtD
Saxagliptin—Infestation—Mycophenolic acid—systemic scleroderma	0.00108	0.00328	CcSEcCtD
Saxagliptin—Pancreatitis—Lisinopril—systemic scleroderma	0.00107	0.00324	CcSEcCtD
Saxagliptin—Face oedema—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00324	CcSEcCtD
Saxagliptin—Sinusitis—Leflunomide—systemic scleroderma	0.00107	0.00322	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00106	0.00319	CcSEcCtD
Saxagliptin—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.00105	0.00318	CcSEcCtD
Saxagliptin—Arthralgia—Mometasone—systemic scleroderma	0.00104	0.00316	CcSEcCtD
Saxagliptin—Myalgia—Mometasone—systemic scleroderma	0.00104	0.00316	CcSEcCtD
Saxagliptin—Blood creatinine increased—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00314	CcSEcCtD
Saxagliptin—ABCC1—tendon—systemic scleroderma	0.00104	0.0229	CbGeAlD
Saxagliptin—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00102	0.00309	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.00102	0.00308	CcSEcCtD
Saxagliptin—Sinusitis—Mycophenolic acid—systemic scleroderma	0.00102	0.00307	CcSEcCtD
Saxagliptin—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00101	0.00305	CcSEcCtD
Saxagliptin—Oedema peripheral—Leflunomide—systemic scleroderma	0.001	0.00304	CcSEcCtD
Saxagliptin—Anaphylactic shock—Mometasone—systemic scleroderma	0.001	0.00303	CcSEcCtD
Saxagliptin—Infection—Mometasone—systemic scleroderma	0.000994	0.00301	CcSEcCtD
Saxagliptin—Angioedema—Captopril—systemic scleroderma	0.000984	0.00297	CcSEcCtD
Saxagliptin—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.000982	0.00297	CcSEcCtD
Saxagliptin—Immune system disorder—Azathioprine—systemic scleroderma	0.000975	0.00295	CcSEcCtD
Saxagliptin—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000958	0.0029	CcSEcCtD
Saxagliptin—Urinary tract infection—Lisinopril—systemic scleroderma	0.000949	0.00287	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000949	0.00287	CcSEcCtD
Saxagliptin—Pancreatitis—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00284	CcSEcCtD
Saxagliptin—Urticaria—Pentoxifylline—systemic scleroderma	0.000922	0.00279	CcSEcCtD
Saxagliptin—Immune system disorder—Leflunomide—systemic scleroderma	0.000921	0.00278	CcSEcCtD
Saxagliptin—Myalgia—Captopril—systemic scleroderma	0.000917	0.00277	CcSEcCtD
Saxagliptin—Arthralgia—Captopril—systemic scleroderma	0.000917	0.00277	CcSEcCtD
Saxagliptin—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000917	0.00277	CcSEcCtD
Saxagliptin—Sinusitis—Lisinopril—systemic scleroderma	0.000916	0.00277	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000912	0.00276	CcSEcCtD
Saxagliptin—ABCC1—lung—systemic scleroderma	0.00091	0.0201	CbGeAlD
Saxagliptin—Malnutrition—Leflunomide—systemic scleroderma	0.000888	0.00268	CcSEcCtD
Saxagliptin—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.000883	0.00267	CcSEcCtD
Saxagliptin—Dyspepsia—Mometasone—systemic scleroderma	0.000881	0.00266	CcSEcCtD
Saxagliptin—Anaphylactic shock—Captopril—systemic scleroderma	0.000879	0.00266	CcSEcCtD
Saxagliptin—Flatulence—Leflunomide—systemic scleroderma	0.000875	0.00264	CcSEcCtD
Saxagliptin—Oedema peripheral—Lisinopril—systemic scleroderma	0.000863	0.00261	CcSEcCtD
Saxagliptin—Fatigue—Mometasone—systemic scleroderma	0.000863	0.00261	CcSEcCtD
Saxagliptin—Thrombocytopenia—Captopril—systemic scleroderma	0.000861	0.0026	CcSEcCtD
Saxagliptin—Infestation—Mycophenolate mofetil—systemic scleroderma	0.000855	0.00258	CcSEcCtD
Saxagliptin—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.000855	0.00258	CcSEcCtD
Saxagliptin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000855	0.00258	CcSEcCtD
Saxagliptin—Malnutrition—Mycophenolic acid—systemic scleroderma	0.000847	0.00256	CcSEcCtD
Saxagliptin—CYP3A5—digestive system—systemic scleroderma	0.000837	0.0185	CbGeAlD
Saxagliptin—Flatulence—Mycophenolic acid—systemic scleroderma	0.000835	0.00252	CcSEcCtD
Saxagliptin—Asthenia—Pentoxifylline—systemic scleroderma	0.000832	0.00252	CcSEcCtD
Saxagliptin—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.000831	0.00251	CcSEcCtD
Saxagliptin—Pruritus—Pentoxifylline—systemic scleroderma	0.000821	0.00248	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000818	0.00247	CcSEcCtD
Saxagliptin—Angioedema—Leflunomide—systemic scleroderma	0.000811	0.00245	CcSEcCtD
Saxagliptin—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000802	0.00243	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000801	0.00242	CcSEcCtD
Saxagliptin—Arthralgia—Azathioprine—systemic scleroderma	0.0008	0.00242	CcSEcCtD
Saxagliptin—Myalgia—Azathioprine—systemic scleroderma	0.0008	0.00242	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000795	0.0024	CcSEcCtD
Saxagliptin—Abdominal pain—Mometasone—systemic scleroderma	0.000791	0.00239	CcSEcCtD
Saxagliptin—Purpura—Prednisone—systemic scleroderma	0.000781	0.00236	CcSEcCtD
Saxagliptin—Dyspepsia—Captopril—systemic scleroderma	0.000774	0.00234	CcSEcCtD
Saxagliptin—Dizziness—Pentoxifylline—systemic scleroderma	0.000767	0.00232	CcSEcCtD
Saxagliptin—Malnutrition—Lisinopril—systemic scleroderma	0.000763	0.00231	CcSEcCtD
Saxagliptin—Infection—Azathioprine—systemic scleroderma	0.000762	0.0023	CcSEcCtD
Saxagliptin—Fatigue—Captopril—systemic scleroderma	0.000758	0.00229	CcSEcCtD
Saxagliptin—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000756	0.00229	CcSEcCtD
Saxagliptin—Arthralgia—Leflunomide—systemic scleroderma	0.000756	0.00228	CcSEcCtD
Saxagliptin—Myalgia—Leflunomide—systemic scleroderma	0.000756	0.00228	CcSEcCtD
Saxagliptin—Flatulence—Lisinopril—systemic scleroderma	0.000752	0.00227	CcSEcCtD
Saxagliptin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000751	0.00227	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000751	0.00227	CcSEcCtD
Saxagliptin—Skin disorder—Azathioprine—systemic scleroderma	0.000745	0.00225	CcSEcCtD
Saxagliptin—Vomiting—Pentoxifylline—systemic scleroderma	0.000738	0.00223	CcSEcCtD
Saxagliptin—Rash—Pentoxifylline—systemic scleroderma	0.000731	0.00221	CcSEcCtD
Saxagliptin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000731	0.00221	CcSEcCtD
Saxagliptin—Headache—Pentoxifylline—systemic scleroderma	0.000727	0.0022	CcSEcCtD
Saxagliptin—Face oedema—Prednisone—systemic scleroderma	0.000726	0.0022	CcSEcCtD
Saxagliptin—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000725	0.00219	CcSEcCtD
Saxagliptin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000721	0.00218	CcSEcCtD
Saxagliptin—Myalgia—Mycophenolic acid—systemic scleroderma	0.000721	0.00218	CcSEcCtD
Saxagliptin—Infection—Leflunomide—systemic scleroderma	0.00072	0.00218	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000719	0.00217	CcSEcCtD
Saxagliptin—Asthenia—Mometasone—systemic scleroderma	0.000718	0.00217	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000716	0.00216	CcSEcCtD
Saxagliptin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000709	0.00214	CcSEcCtD
Saxagliptin—Pruritus—Mometasone—systemic scleroderma	0.000708	0.00214	CcSEcCtD
Saxagliptin—Skin disorder—Leflunomide—systemic scleroderma	0.000704	0.00213	CcSEcCtD
Saxagliptin—CYP3A5—lung—systemic scleroderma	0.000699	0.0155	CbGeAlD
Saxagliptin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000699	0.00211	CcSEcCtD
Saxagliptin—Angioedema—Lisinopril—systemic scleroderma	0.000697	0.00211	CcSEcCtD
Saxagliptin—Abdominal pain—Captopril—systemic scleroderma	0.000695	0.0021	CcSEcCtD
Saxagliptin—Nausea—Pentoxifylline—systemic scleroderma	0.000689	0.00208	CcSEcCtD
Saxagliptin—Infection—Mycophenolic acid—systemic scleroderma	0.000687	0.00208	CcSEcCtD
Saxagliptin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000677	0.00205	CcSEcCtD
Saxagliptin—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000671	0.00203	CcSEcCtD
Saxagliptin—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000668	0.00202	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000662	0.002	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00066	0.002	CcSEcCtD
Saxagliptin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000659	0.00199	CcSEcCtD
Saxagliptin—Myalgia—Lisinopril—systemic scleroderma	0.000649	0.00196	CcSEcCtD
Saxagliptin—Arthralgia—Lisinopril—systemic scleroderma	0.000649	0.00196	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000645	0.00195	CcSEcCtD
Saxagliptin—Dyspepsia—Leflunomide—systemic scleroderma	0.000638	0.00193	CcSEcCtD
Saxagliptin—Pancreatitis—Prednisone—systemic scleroderma	0.000637	0.00193	CcSEcCtD
Saxagliptin—Vomiting—Mometasone—systemic scleroderma	0.000636	0.00192	CcSEcCtD
Saxagliptin—Rash—Mometasone—systemic scleroderma	0.000631	0.00191	CcSEcCtD
Saxagliptin—Asthenia—Captopril—systemic scleroderma	0.000631	0.00191	CcSEcCtD
Saxagliptin—Dermatitis—Mometasone—systemic scleroderma	0.000631	0.00191	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00063	0.0019	CcSEcCtD
Saxagliptin—CYP3A4—digestive system—systemic scleroderma	0.000628	0.0139	CbGeAlD
Saxagliptin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000627	0.0019	CcSEcCtD
Saxagliptin—Headache—Mometasone—systemic scleroderma	0.000627	0.0019	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000626	0.00189	CcSEcCtD
Saxagliptin—Fatigue—Leflunomide—systemic scleroderma	0.000625	0.00189	CcSEcCtD
Saxagliptin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000623	0.00188	CcSEcCtD
Saxagliptin—Pruritus—Captopril—systemic scleroderma	0.000622	0.00188	CcSEcCtD
Saxagliptin—Infection—Lisinopril—systemic scleroderma	0.000619	0.00187	CcSEcCtD
Saxagliptin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00185	CcSEcCtD
Saxagliptin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00061	0.00184	CcSEcCtD
Saxagliptin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000608	0.00184	CcSEcCtD
Saxagliptin—Abdominal pain—Azathioprine—systemic scleroderma	0.000607	0.00183	CcSEcCtD
Saxagliptin—Skin disorder—Lisinopril—systemic scleroderma	0.000605	0.00183	CcSEcCtD
Saxagliptin—Erectile dysfunction—Prednisone—systemic scleroderma	0.000599	0.00181	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000597	0.0018	CcSEcCtD
Saxagliptin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000596	0.0018	CcSEcCtD
Saxagliptin—Nausea—Mometasone—systemic scleroderma	0.000595	0.0018	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000592	0.00179	CcSEcCtD
Saxagliptin—Dizziness—Captopril—systemic scleroderma	0.000581	0.00176	CcSEcCtD
Saxagliptin—Urticaria—Leflunomide—systemic scleroderma	0.000576	0.00174	CcSEcCtD
Saxagliptin—Abdominal pain—Leflunomide—systemic scleroderma	0.000573	0.00173	CcSEcCtD
Saxagliptin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00172	CcSEcCtD
Saxagliptin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00172	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000567	0.00171	CcSEcCtD
Saxagliptin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000565	0.00171	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000565	0.00171	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000565	0.00171	CcSEcCtD
Saxagliptin—Vomiting—Captopril—systemic scleroderma	0.000559	0.00169	CcSEcCtD
Saxagliptin—Rash—Captopril—systemic scleroderma	0.000554	0.00168	CcSEcCtD
Saxagliptin—Dermatitis—Captopril—systemic scleroderma	0.000554	0.00167	CcSEcCtD
Saxagliptin—Headache—Captopril—systemic scleroderma	0.000551	0.00166	CcSEcCtD
Saxagliptin—Dyspepsia—Lisinopril—systemic scleroderma	0.000548	0.00166	CcSEcCtD
Saxagliptin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000546	0.00165	CcSEcCtD
Saxagliptin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00165	CcSEcCtD
Saxagliptin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000542	0.00164	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000537	0.00162	CcSEcCtD
Saxagliptin—Fatigue—Lisinopril—systemic scleroderma	0.000537	0.00162	CcSEcCtD
Saxagliptin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000534	0.00161	CcSEcCtD
Saxagliptin—Hypersensitivity—Leflunomide—systemic scleroderma	0.000534	0.00161	CcSEcCtD
Saxagliptin—Pancreatitis—Methotrexate—systemic scleroderma	0.000533	0.00161	CcSEcCtD
Saxagliptin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00053	0.0016	CcSEcCtD
Saxagliptin—Nausea—Captopril—systemic scleroderma	0.000522	0.00158	CcSEcCtD
Saxagliptin—Asthenia—Leflunomide—systemic scleroderma	0.00052	0.00157	CcSEcCtD
Saxagliptin—Pruritus—Leflunomide—systemic scleroderma	0.000513	0.00155	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000509	0.00154	CcSEcCtD
Saxagliptin—Dizziness—Azathioprine—systemic scleroderma	0.000507	0.00153	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000505	0.00153	CcSEcCtD
Saxagliptin—Erectile dysfunction—Methotrexate—systemic scleroderma	0.0005	0.00151	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000497	0.0015	CcSEcCtD
Saxagliptin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000496	0.0015	CcSEcCtD
Saxagliptin—Urticaria—Lisinopril—systemic scleroderma	0.000495	0.00149	CcSEcCtD
Saxagliptin—Abdominal pain—Lisinopril—systemic scleroderma	0.000492	0.00149	CcSEcCtD
Saxagliptin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000489	0.00148	CcSEcCtD
Saxagliptin—Vomiting—Azathioprine—systemic scleroderma	0.000488	0.00147	CcSEcCtD
Saxagliptin—Infestation—Methotrexate—systemic scleroderma	0.000485	0.00146	CcSEcCtD
Saxagliptin—Infestation NOS—Methotrexate—systemic scleroderma	0.000485	0.00146	CcSEcCtD
Saxagliptin—Rash—Azathioprine—systemic scleroderma	0.000484	0.00146	CcSEcCtD
Saxagliptin—Dermatitis—Azathioprine—systemic scleroderma	0.000483	0.00146	CcSEcCtD
Saxagliptin—Headache—Azathioprine—systemic scleroderma	0.000481	0.00145	CcSEcCtD
Saxagliptin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00048	0.00145	CcSEcCtD
Saxagliptin—Dizziness—Leflunomide—systemic scleroderma	0.000479	0.00145	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000471	0.00142	CcSEcCtD
Saxagliptin—Immune system disorder—Prednisone—systemic scleroderma	0.00047	0.00142	CcSEcCtD
Saxagliptin—Vomiting—Leflunomide—systemic scleroderma	0.000461	0.00139	CcSEcCtD
Saxagliptin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000459	0.00139	CcSEcCtD
Saxagliptin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000457	0.00138	CcSEcCtD
Saxagliptin—Rash—Leflunomide—systemic scleroderma	0.000457	0.00138	CcSEcCtD
Saxagliptin—Dermatitis—Leflunomide—systemic scleroderma	0.000456	0.00138	CcSEcCtD
Saxagliptin—Nausea—Azathioprine—systemic scleroderma	0.000456	0.00138	CcSEcCtD
Saxagliptin—Headache—Leflunomide—systemic scleroderma	0.000454	0.00137	CcSEcCtD
Saxagliptin—Malnutrition—Prednisone—systemic scleroderma	0.000453	0.00137	CcSEcCtD
Saxagliptin—Asthenia—Lisinopril—systemic scleroderma	0.000447	0.00135	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000446	0.00135	CcSEcCtD
Saxagliptin—Pruritus—Lisinopril—systemic scleroderma	0.00044	0.00133	CcSEcCtD
Saxagliptin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000439	0.00133	CcSEcCtD
Saxagliptin—Rash—Mycophenolic acid—systemic scleroderma	0.000436	0.00132	CcSEcCtD
Saxagliptin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000435	0.00132	CcSEcCtD
Saxagliptin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000433	0.00131	CcSEcCtD
Saxagliptin—Headache—Mycophenolic acid—systemic scleroderma	0.000433	0.00131	CcSEcCtD
Saxagliptin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000431	0.0013	CcSEcCtD
Saxagliptin—Nausea—Leflunomide—systemic scleroderma	0.00043	0.0013	CcSEcCtD
Saxagliptin—Angioedema—Prednisone—systemic scleroderma	0.000414	0.00125	CcSEcCtD
Saxagliptin—Dizziness—Lisinopril—systemic scleroderma	0.000412	0.00124	CcSEcCtD
Saxagliptin—Nausea—Mycophenolic acid—systemic scleroderma	0.000411	0.00124	CcSEcCtD
Saxagliptin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00121	CcSEcCtD
Saxagliptin—Vomiting—Lisinopril—systemic scleroderma	0.000396	0.0012	CcSEcCtD
Saxagliptin—Immune system disorder—Methotrexate—systemic scleroderma	0.000393	0.00119	CcSEcCtD
Saxagliptin—Rash—Lisinopril—systemic scleroderma	0.000393	0.00119	CcSEcCtD
Saxagliptin—Dermatitis—Lisinopril—systemic scleroderma	0.000392	0.00119	CcSEcCtD
Saxagliptin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000391	0.00118	CcSEcCtD
Saxagliptin—Headache—Lisinopril—systemic scleroderma	0.00039	0.00118	CcSEcCtD
Saxagliptin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000386	0.00117	CcSEcCtD
Saxagliptin—Arthralgia—Prednisone—systemic scleroderma	0.000386	0.00117	CcSEcCtD
Saxagliptin—Myalgia—Prednisone—systemic scleroderma	0.000386	0.00117	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000383	0.00116	CcSEcCtD
Saxagliptin—Malnutrition—Methotrexate—systemic scleroderma	0.000379	0.00114	CcSEcCtD
Saxagliptin—Nausea—Lisinopril—systemic scleroderma	0.00037	0.00112	CcSEcCtD
Saxagliptin—Anaphylactic shock—Prednisone—systemic scleroderma	0.00037	0.00112	CcSEcCtD
Saxagliptin—Infection—Prednisone—systemic scleroderma	0.000367	0.00111	CcSEcCtD
Saxagliptin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00109	CcSEcCtD
Saxagliptin—Skin disorder—Prednisone—systemic scleroderma	0.000359	0.00109	CcSEcCtD
Saxagliptin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000347	0.00105	CcSEcCtD
Saxagliptin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00104	CcSEcCtD
Saxagliptin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00104	CcSEcCtD
Saxagliptin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00103	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000337	0.00102	CcSEcCtD
Saxagliptin—Dyspepsia—Prednisone—systemic scleroderma	0.000325	0.000984	CcSEcCtD
Saxagliptin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000979	CcSEcCtD
Saxagliptin—Arthralgia—Methotrexate—systemic scleroderma	0.000322	0.000974	CcSEcCtD
Saxagliptin—Myalgia—Methotrexate—systemic scleroderma	0.000322	0.000974	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00032	0.000968	CcSEcCtD
Saxagliptin—Fatigue—Prednisone—systemic scleroderma	0.000319	0.000963	CcSEcCtD
Saxagliptin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000309	0.000934	CcSEcCtD
Saxagliptin—Infection—Methotrexate—systemic scleroderma	0.000307	0.000928	CcSEcCtD
Saxagliptin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000303	0.000914	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000302	0.000914	CcSEcCtD
Saxagliptin—Skin disorder—Methotrexate—systemic scleroderma	0.0003	0.000907	CcSEcCtD
Saxagliptin—Urticaria—Prednisone—systemic scleroderma	0.000294	0.000888	CcSEcCtD
Saxagliptin—Abdominal pain—Prednisone—systemic scleroderma	0.000292	0.000883	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000282	0.000851	CcSEcCtD
Saxagliptin—Hypersensitivity—Prednisone—systemic scleroderma	0.000272	0.000823	CcSEcCtD
Saxagliptin—Dyspepsia—Methotrexate—systemic scleroderma	0.000272	0.000822	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000267	0.000806	CcSEcCtD
Saxagliptin—Fatigue—Methotrexate—systemic scleroderma	0.000266	0.000805	CcSEcCtD
Saxagliptin—Asthenia—Prednisone—systemic scleroderma	0.000265	0.000802	CcSEcCtD
Saxagliptin—Pruritus—Prednisone—systemic scleroderma	0.000262	0.000791	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000253	0.000764	CcSEcCtD
Saxagliptin—Urticaria—Methotrexate—systemic scleroderma	0.000245	0.000742	CcSEcCtD
Saxagliptin—Dizziness—Prednisone—systemic scleroderma	0.000245	0.000739	CcSEcCtD
Saxagliptin—Abdominal pain—Methotrexate—systemic scleroderma	0.000244	0.000738	CcSEcCtD
Saxagliptin—Vomiting—Prednisone—systemic scleroderma	0.000235	0.000711	CcSEcCtD
Saxagliptin—Rash—Prednisone—systemic scleroderma	0.000233	0.000705	CcSEcCtD
Saxagliptin—Dermatitis—Prednisone—systemic scleroderma	0.000233	0.000704	CcSEcCtD
Saxagliptin—Headache—Prednisone—systemic scleroderma	0.000232	0.0007	CcSEcCtD
Saxagliptin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000228	0.000688	CcSEcCtD
Saxagliptin—Asthenia—Methotrexate—systemic scleroderma	0.000222	0.00067	CcSEcCtD
Saxagliptin—Nausea—Prednisone—systemic scleroderma	0.00022	0.000664	CcSEcCtD
Saxagliptin—Pruritus—Methotrexate—systemic scleroderma	0.000219	0.000661	CcSEcCtD
Saxagliptin—Dizziness—Methotrexate—systemic scleroderma	0.000204	0.000618	CcSEcCtD
Saxagliptin—Vomiting—Methotrexate—systemic scleroderma	0.000196	0.000594	CcSEcCtD
Saxagliptin—Rash—Methotrexate—systemic scleroderma	0.000195	0.000589	CcSEcCtD
Saxagliptin—Dermatitis—Methotrexate—systemic scleroderma	0.000195	0.000588	CcSEcCtD
Saxagliptin—Headache—Methotrexate—systemic scleroderma	0.000194	0.000585	CcSEcCtD
Saxagliptin—Nausea—Methotrexate—systemic scleroderma	0.000184	0.000555	CcSEcCtD
